QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GRAL

QT57GRAIL, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
63.74
+4.29+7.22%
OverviewShort InterestFilings
GRALQT57GRAIL, Inc.·NASDAQ
OverviewShort InterestFilings
63.74+7.22%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-10.37
Insider Own23.61%
Shs Outstand42.92M
Perf Week5.95%
Market Cap2.55BForward P/E-EPS next Y-10.65Insider Trans-0.73%Shs Float-Perf Month4.51%
Enterprise Value2.53BPEG-EPS next Q-2.65Inst Own-Short Float-Perf Quarter31.50%
Income-417407613.00P/S16.34EPS this Y0.16%Inst Trans-Short Ratio-Perf Half Y-26.75%
Sales156.12MP/B0.97EPS next Y-2.88%ROA-14.10%Short Interest-Perf YTD-25.53%
Book/sh58.27P/C-EPS next 5Y-ROE-16.42%52W High118.83 -46.36%Perf Year51.58%
Cash/sh19.18P/FCF-EPS past 3/5Y-ROIC-15.24%52W Low29.95 112.82%Perf 3Y-
Dividend Est.-EV/EBITDA-7.50Sales past 3/5Y37.95% -Gross Margin-14.80%Volatility5.06% 7.19%Perf 5Y-
Dividend TTM-EV/Sales16.23EPS Y/Y TTM83.68%Oper. Margin-348.66%ATR (14)4.68Perf 10Y-
Dividend Ex-Date-Quick Ratio11.51Sales Y/Y TTM24.60%Profit Margin-253.22%RSI (14)54.02Recom2.50
Dividend Gr. 3/5Y-Current Ratio11.74EPS Q/Q26.13%SMA20-0.04%Beta2.71Target Price73.43
Payout0.00%Debt/Eq0.02Sales Q/Q28.13%SMA508.64%Rel Volume1.61Prev Close59.45
Employees1,000LT Debt/Eq0.03EarningsAug 11SMA200-10.80%Avg Volume722.95KPrice63.74
IPO DateJun 12, 2024Option/ShortYes / YesEPS/Sales Surpr.17.11% 5.13%Net Debt/EBITDA0.05Volume1,164,502Change7.22%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-05-26ReiteratedGoldman Sachs$60
May-06-26ReiteratedRobert W. Baird$82 → $70
May-06-26ReiteratedPiper SandlerNeutral$54 → $56
Apr-10-26InitiatedMizuhoNeutral$58
Apr-10-26InitiatedPiper SandlerNeutral$54
Feb-24-26ReiteratedMorgan StanleyEqual Weight$110 → $60
Feb-20-26ReiteratedRobert W. Baird$113 → $82
Feb-20-26ReiteratedCanaccord GenuityBuy$85 → $80
Feb-17-26InitiatedBairdOutperform$113
Jan-26-26ReiteratedGuggenheimBuy$100 → $130
Latest News
Jun-12-26
Jun-12-2607:57AM
Caris Life Sciences: The Discount To Peers Looks Hard To IgnoreSeekingAlpha
Jun-10-26
Jun-10-2602:12AM
GRAIL, Inc. (GRAL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue157147126
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A179210204
Gross Profit-23-63-78
Selling, General and Administrative Excl. Other268276368
Research and Development191196322
Other Operating Expense6201,421
Operating Income-544-534-2,189
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-510-1,421
Net Income Before Taxes-517-535-2,162
Income Taxes-120-126-135
Consolidated Net Income-395-408-2,027
Net Income From Continuing Operations-395-408-2,027
Net Income-395-408-2,027
EPS (Recurring)-10.37-11.11-63.54
EPS (Basic, Before Extraordinaries)-10.37-11.11-63.54
EPS (Diluted)-10.37-11.11-63.54
EBITDA-339-378-610
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio16.6521.54—
Gross Margin-14.65-42.86-61.90
Operating Margin-346.50-363.27-1,737.30
Net Margin-251.59-277.55-1,608.73
Shares Outstanding413732
Market Capitalization2,6133,167—
Operating Lease Expense
———
Insider Trading Volume
$69.27$64.35$59.42$54.49$49.57● Close Price0.00M20.00M39.99M59.99M79.98MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Partridge Andrew JohnChief Growth OfficerJun 04 '26Sale61.081,49191,070163,738Jun 05 12:00 AM
Freidin AaronChief Financial OfficerApr 08 '26Sale49.9245,8062,286,526260,669Apr 09 12:00 AM
RAGUSA ROBERT PChief Executive OfficerApr 08 '26Sale49.92123,5026,164,923518,582Apr 09 12:00 AM
Ofman Joshua J.PresidentApr 08 '26Sale49.9261,6653,078,169371,216Apr 09 12:00 AM
RAGUSA ROBERT PChief Executive OfficerMar 09 '26Sale47.897,461357,296642,084Mar 09 12:00 AM
Freidin AaronChief Financial OfficerMar 09 '26Sale47.892,492119,341306,475Mar 09 12:00 AM
Ofman Joshua J.PresidentMar 09 '26Sale47.892,937140,650432,881Mar 09 12:00 AM
RAGUSA ROBERT PChief Executive OfficerMar 05 '26Sale53.0198051,950649,545Mar 09 12:00 AM
Ofman Joshua J.PresidentMar 05 '26Sale53.0169036,577435,818Mar 09 12:00 AM
Freidin AaronChief Financial OfficerMar 05 '26Sale53.0165534,722308,967Mar 09 12:00 AM
RAGUSA ROBERT PChief Executive OfficerMar 02 '26Sale50.1737,5041,881,417650,525Mar 03 12:00 AM
Ofman Joshua J.PresidentMar 02 '26Sale50.1617,002852,848436,508Mar 03 12:00 AM
Freidin AaronChief Financial OfficerMar 02 '26Sale50.179,573480,244309,622Mar 03 12:00 AM
RAGUSA ROBERT PChief Executive OfficerDec 03 '25Sale95.2440,0003,809,535688,029Dec 05 12:00 AM
Ofman Joshua J.PresidentDec 03 '25Sale100.0013,0001,300,000368,818Dec 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR